Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant carboplatin and paclitaxel with fertility-preserving conservative surgery in cervical cancer
2017-003102-40Phase 2Terminated
- Sponsor
- Netherlands Cancer Institute
- Start
- Nov 2018
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carboplatin, paclitaxel in Cervical Cancer (CC), sponsored by Netherlands Cancer Institute. Started Nov 2018; status: terminated.
02
Drugs
carboplatinpaclitaxel
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on 2017-003102-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003102-40.